| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC1566 |
| Trial ID | NCT02602249 |
| Disease | Gastric Cancer |
| Altered gene | MUC1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | MUC1-gene-DC-CTL |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Phase 1 Study of Antigen-specific Cytotoxic T Lymphocytes Induced by Dendritic Cells Infected by Recombinant Adeno-associated Virus With MUC1 Gene(MUC1-gene-DC-CTL) or Directly Pulsed by MUC1 Peptide(MUC1-peptide-DC-CTL) in Gastric Cancer. |
| Year | 2015 |
| Country | China |
| Company sponsor | Beijing Doing Biomedical Co., Ltd. |
| Other ID(s) | Doing-003 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||
|
|||||||||||